Company / Revenue
PAVmed Inc. Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$3.0M
FY2025
5-year range
$500.0K / $3.0M
FY2021-FY2025
Trend
-0.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2025 with a 3-year CAGR of +81.6%.
Improved from $3M to $3M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +81.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +81.6%, indicating consistent growth.
- In FY2025, revenue decreased 0.2% year-over-year.
- Peak revenue was recorded in FY2024.
- Lowest revenue in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0M | -0.2% |
| FY2024 | $3.0M | +20.0% |
| FY2023 | $2.5M | +400.0% |
| FY2022 | $500.0K | +0.0% |
| FY2021 | $500.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026